• In June, Cheung Kong Infrastructure Holdings has changed its name to CK Infrastructure Holdings Limited.

  • In June, Hutchison China MediTech Limited (Chi-Med) filed a New Drug Application in China for Fruquintinib in colorectal cancer patients, which is the first ever home-grown, Chinese-discovered and developed drug in a mainstream therapeutic area to get through all clinical trials in China.